Market Research Logo

Indonesia Pharmaceuticals and Healthcare Report Q4 2017

Indonesia Pharmaceuticals and Healthcare Report Q4 2017

BMI View:

Indonesia's pharmaceutical market will continue to be of interest to foreign companies. Maindraws include a large and growing population, increased per capita disposable income and gradualimprovements in the country's business climate. On the other hand, the country's patent protection remainsbelow par, which will hamper investment into the patented drug segment, as will concerns over financialviability over the universal healthcare coverage scheme.

Headline Expenditure Projections

Pharmaceuticals: IDR85.6trn (USD6.4bn) in 2016 to IDR94.2trn (USD7.0bn) in 2017; +10.2% growthin local currency terms and +8.3% in US dollar terms.

Healthcare: IDR363.7trn (USD27.329.bn) in 2016 to IDR403.1trn (USD29.8bn) in 2017; +10.5%growth in local currency terms and +9.0% in US dollar terms.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Indonesia 2015-2021)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Indonesia 2013-2021)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Indonesia 2013-2021)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Indonesia 2013-2021)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Indonesia 2013-2021)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Indonesia 2013-2021)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Indonesia 2013-2021)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Indonesia 2013-2021)
OTC Drug Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Indonesia 2013-2021)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Indonesia 2015-2021)
Table: Pharmaceutical Trade Data And Forecasts local currency (Indonesia 2015-2021)
Industry Risk/Reward Index
Asia Pacific Pharmaceuticals: Diverse Opportunities And Inherent Risks
Regulatory Review
Intellectual Property Issues
Table: Special 301 Submission 2017: Issues Raised For Indonesia
Pricing Regime
Reimbursement Regime
Industry Trends And Developments
Market Overview
Table: UN Millennium Development Goals For Indonesia
Healthcare Sector
Table: Examples Of JKN Benefits
Table: Healthcare Resources (Indonesia 2011-2016)
Table: Healthcare Personnel (Indonesia 2011-2016)
Table: Healthcare Activity (Indonesia 2011-2016)
Research & Development
Clinical Trials
Epidemiology
Table: Estimated Number Of New Cases Of Cancer In Indonesia
Competitive Landscape
Research-Based Industry
Table: Selected List Of Pharmaceutical Business Areas With Restricted Conditions
Table: Multinational Market Activity
Generic Drugmakers
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
Bayer
Darya-Varia Group
GlaxoSmithKline
Indofarma
Kimia Farma
Merck & Co
Merck Group
Novartis
Pfizer
PT Bio Farma
PT Kalbe Farma
Sanofi
Soho Group
Demographic Forecast
Demographic Outlook
Table: Population Headline Indicators (Indonesia 1990-2025)
Table: Key Population Ratios (Indonesia 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Indonesia 1990-2025)
Table: Population By Age Group (Indonesia 1990-2025)
Table: Population By Age Group % (Indonesia 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Table: Indicators - Rationale And Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report